Proteome Sciences & Medical Solutions in biomarker alliance:
This article was originally published in Clinica
Executive Summary
UK firms Proteome Sciences and Medical Solutions are entering into a co-marketing agreement to promote their technologies towards the use of protein biomarkers in diagnostic testing. Cobham, Surrey-based Proteome Sciences, uses its proprietary ProteoSHOP technology, comprising two-dimensional gel-based electrophoresis and gel-free protein sequence tagging to identify markers in body fluids and tissue. Medical Solutions targets diagnostic pathology products at the NHS and UK private sector. By combining their technologies, the firms hope to offer customers a "seamless workflow from biomarker discovery through to implementation in diagnostics and drug development".
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.